Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry. AI is already rapidly redefining how we discover and design biologics ...

Despite decades of progress in pharmaceutical R&D, the earliest phase of drug discovery—where molecules are conceived and designed—remains costly, inefficient, and burdened by high failure rates. Most ...